当前位置: X-MOL 学术Expert Opin. Drug Deliv. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson’s disease: is it an improvement on other delivery?
Expert Opinion on Drug Delivery ( IF 6.6 ) Pub Date : 2023-09-10 , DOI: 10.1080/17425247.2023.2253146
Sheila A Doggrell 1
Affiliation  

Parkinson’s disease (PD) is the second most common neurodegenerative disease and is growing in prevalence and disability. The standard treatment for PD is oral levo-dopa (LD) with carbidopa (CD). A...

中文翻译:

连续皮下注射左旋多巴-卡比多巴治疗晚期帕金森病:它是其他分娩方式的改进吗?

帕金森病 (PD) 是第二常见的神经退行性疾病,其患病率和致残率正在不断上升。PD 的标准治疗是口服左旋多巴 (LD) 联合卡比多巴 (CD)。A...
更新日期:2023-09-10
down
wechat
bug